-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Sage Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2020 to Q3 2024.
- Sage Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.53 USD/shares, a 54.6% increase year-over-year.
- Sage Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -5.57 USD/shares, a 49.3% increase year-over-year.
- Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -9.05 USD/shares, a 0.78% decline from 2022.
- Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -8.98 USD/shares, a 15.1% decline from 2021.
- Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -7.8 USD/shares, a 167% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)